Precision BioSciences announced the formation of its Scientific Advisory Board (SAB) with four key appointments: Kenneth C. Anderson, M.D., Hagop Kantarjian, M.D., Raymond Schinazi, Ph.D., D.Sc. and Cameron Turtle, MBBS, Ph.D. Drs. Anderson, Kantarjian, Schinazi and Turtle bring to Precision deep expertise in hematological malignancies, immuno-oncology and infectious disease with demonstrated success guiding innovative new therapies through clinical development and FDA approval. It is anticipated that the SAB members will work closely with Precision as it advances its genome editing programs through preclinical and clinical product development. Kenneth C. Anderson, M.D. is the program director of the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at the Dana-Farber Cancer Institute and Kraft Family Professor of Medicine at Harvard Medical School. Hagop Kantarjian, M.D. is chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, where he is also the Samsung Distinguished Leukemia Chair in Cancer Medicine. Raymond Schinazi, Ph.D, D.Sc. is the Frances Winship Walters Professor of Pediatrics and director of the Laboratory of Biochemical Pharmacology at Emory University. Cameron Turtle, MBBS, Ph.D. is an associate member at Fred Hutchinson Cancer Research Center and an associate professor at the University of Washington.